# US 2024/0047091 A1 · Device and method for producing medical isotopes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0047091 A1
- Document ID: US20240047091A1
- Status: Published application
- Kind: A1
- Application number: 18/489,707
- Filed: 2023-10-18
- Published: 2024-02-08
- Earliest claimed: 2008-05-02
- Assignees: SHINE Technologies, LLC
- Applicants: SHINE Technologies, LLC
- Inventors: Gregory Piefer
- Web page: https://patentgrep.com/patent/US20240047091A1

## CPC

- G21G 1/08: accompanied by nuclear fission
- G21C 1/303: {Experimental or irradiation arrangements inside the reactor (irradiation loops G21C1/306)}
- G21B 1/01: Hybrid fission-fusion nuclear reactors
- Y02E 30/10: Nuclear fusion reactors
- Y02E 30/30: Nuclear fission reactors
- G21G: CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES (applications of radiation in general G21H5/00; handling particles, e.g. neutrons, or electromagnetic radiation not otherwise provided for G21K)
- G21C: NUCLEAR REACTORS (fusion reactors, hybrid fission-fusion reactors G21B; nuclear explosives G21J)
- G21B: FUSION REACTORS (uncontrolled reactors G21J)
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

A hybrid nuclear reactor that is operable to produce a medical isotope includes an ion source operable to produce an ion beam from a gas, a target chamber including a target that interacts with the ion beam to produce neutrons, and an activation cell positioned proximate the target chamber and including a parent material that interacts with the neutrons to produce the medical isotope via a fission reaction. An attenuator is positioned proximate the activation cell and selected to maintain the fission reaction at a subcritical level, a reflector is positioned proximate the target chamber and selected to reflect neutrons toward the activation cell, and a moderator substantially surrounds the activation cell, the attenuator, and the reflector.

## Claims

### Claim 1

A method of producing a medical isotope, the method comprising:
exciting a gas to produce an ion beam;
passing the ion beam to a target chamber including a target, the target and the ion beam reacting to produce neutrons;
reacting at least some of the neutrons with a neutron multiplier to produce additional neutrons;
passing at least some of the neutrons to a neutron moderator and producing thermal neutrons;
maintaining a fission reaction at a subcritical level between a parent material and at least some of the neutrons, at least some of the additional neutrons, and at least some of the thermal neutrons, wherein the parent material is positioned in an aqueous solution within an activation cell; and
producing the medical isotope via the fission reaction.

### Claim 2 (depends on 1)

The method of claim 1, wherein the activation cell is positioned proximate the target chamber.

### Claim 3 (depends on 1)

The method of claim 1, wherein the activation cell comprises an annular activation cell.

### Claim 4 (depends on 3)

The method of claim 3, wherein the neutron multiplier is annular and is concentric with the annular activation cell.

### Claim 5 (depends on 3)

The method of claim 3, wherein the neutron moderator is positioned radially outward the annular activation cell.

### Claim 6 (depends on 1)

The method of claim 1, wherein the neutron moderator comprises H2O, D2O, or a combination thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the target and the ion beam react via a fusion reaction to produce the neutrons.

### Claim 8 (depends on 7)

The method of claim 7, wherein the target comprises deuterium, tritium, or helium, or a combination thereof;

### Claim 9 (depends on 7)

The method of claim 7, wherein the gas includes one of deuterium and tritium and the target includes the other of deuterium and tritium.

### Claim 10 (depends on 1)

The method of claim 1, wherein the target comprises a gas.

### Claim 11 (depends on 1)

The method of claim 1, wherein RF resonance is used to produce the ion beam.

### Claim 12 (depends on 1)

The method of claim 1, further comprising accelerating the ion beam with an accelerator positioned between the target chamber and an ion source operable to produce the ion beam from a gas.

### Claim 13 (depends on 1)

The method of claim 1, wherein the target chamber defines a target path that is substantially linear.

### Claim 14 (depends on 13)

The method of claim 13, further comprising positioning at least one magnet to define a magnetic field that collimates the ion beam within at least a portion of the target path.

### Claim 15 (depends on 1)

The method of claim 1, wherein the target chamber defines a target path that is substantially helical.

### Claim 16 (depends on 15)

The method of claim 15, further comprising positioning at least one magnet to define a magnetic field that directs the ion beam along the helical path.

### Claim 17 (depends on 1)

The method of claim 1, wherein the target chamber and an ion source operable to produce the ion beam from a gas together at least partially define one of a plurality of fusion reactors, and wherein the plurality of fusion reactors are positioned proximate the activation cell.

### Claim 18 (depends on 1)

The method of claim 1, wherein the parent material comprises uranium enriched to 20% or less of 235U and the medical isotope is 99Mo.
